October 6, 2015
Join us at CPhI 2015
We are excited about exhibiting at CPhI this year from 13 to 15 October (stand 1A36)
August 28, 2015
EMCM contributes to renal cancer treatment through VCC Medical NV partnership
EMCM recently renewed its partnership with VCC Medical NV to support the production of Reniale - a personalised treatment for renal cancer.
August 6, 2015
Cleanroom facilities upgraded to further improve environmental control
We have completed a series of upgrades, which improved the environmental control within our production facilities.
April 29, 2015
Adcon®Gel registration renewed following KFDA inspection
EMCM – a Leader Biomedical Group company - is proud to announce that our Adcon®Gel registration has been renewed
March 20, 2015
See you in Vegas for the AAOS 2015 Annual Meeting
We are proud to be exhibiting at the AAOS 2015 Annual Meeting
March 3, 2015
EMCM/Leader Biomedical launches DBM
Leader Biomedical Group is pleased to announce the launch of its own line of Demineralised Bone Matrix (DBM)
February 25, 2015
Let's connect at IDS 2015
10-14 March 2015
January 20, 2015
Let's connect at the 11th Middle East Orthopaedics conference
EMCM will be attending the 11th Middle East Orthpaedics conference in Dubai in the United Arab Emirates on 26 and 27 January.
January 6, 2015
New corporate strategy bears first fruit
The corporate strategy of EMCM’s parent company, Leader Biomedical, continues to deliver results, establishing new subsidiaries and global partnerships.
November 12, 2014
EMCM installs fully automated inspection machine for ampoules and vials
Extending its focus strategy, EMCM has made an important step in the further optimisation of their ampoule and vial filling processes.
November 4, 2014
EMCM & UK customer ally for Nutraceutical liquid manufacturing
EMCM is starting a cooperation with a new customer, for a new production process for manufacturing, filling and final packaging of an oral solution.
September 30, 2014
Allograft study recognised at EBJIS, Utrecht, the Netherlands
Dr. D. Link (EMCM) received the award for ‘Best Basic Science Study' , study on osteoconductive properties of cancellous bone graft loaded with antibiotics
September 9, 2014
GMP certified Reniale® production at EMCM
The Dutch Healthcare Inspectorate (IGZ) and Farmatec/CIBG granted EMCM the respective GMP certification
August 8, 2014
CritiTech and European Medical Contract Manufacturing announce collaboration to develop API-coated tissue grafts
CritiTech has entered into a collaboration with EMCM to develop tissue grafts coated with a variety of drugs
August 4, 2014
EMCM B.V. announces future strategic direction
Subsequent to its recent acquisition by a Private Equity, EMCM B.V. today announced the formation of its corporate headquarters and
July 21, 2014
EMCM to be issued Import License for human allografts
EMCM is glad to announce a successful audit by the Dutch Healthcare Inspectorate (IGZ), focusing on the human tissue procurement and processing.
June 11, 2014
Issues in Bone Infection, Biofilm and Bone Defect
Bone infection is known to be one of the major problems in orthopaedic surgery.
February 25, 2014
EMCM acquired by Private Equity firm
European Medical Contract Manufacturing B.V. (EMCM) today announces its acquisition by a British Virgin Island-based Private Equity Company for a price of EUR 18Mn. The transfer of ownership and control is to be completed in April 2014.
September 6, 2013
EMCM an Institutional Member of EATB
EMCM is proud to be an Institutional Member of the European Association of Tissue Banks.
July 3, 2013
EMCM announces strategic partnership with Alamo Tissue Service, San Antonio, TX
European Medical Contract Manufacturing (EMCM) has today announced the closing of a strategic collaboration with Alamo Tissue Service (ATS) in the field of development and manufacturing of human grafts and xenografts using proprietary super critical Carbon Dioxide (scCO2) techniques.
November 13, 2012
NovaSterilis Announces EMCM as Strategic Partner for Supercritical CO2 Sterilisation in Europe and Parts of Asia
NovaSterilis Inc., a leader in the development and commercialisation of supercritical carbon dioxide (scCO2) technology announces the addition of European Medical Contract Manufacturing (EMCM) as a licensee of supercritical CO2 sterilisation and NovaSterilis’ exclusive agent for supercritical CO2 technology and equipment in specified territories.
June 19, 2012
CSR - Osteomyelitis in Uganda
aap Implantate AG, the parent company of EMCM B.V., engage in CSR activities to overcome Osteomyelitis in Uganda by providing PerOssal®, a premium aap product, in the nation at no cost. PerOssal® is a newly developed synthetic bone replacement material with two outstanding properties.
June 5, 2012
Collagen Purification @ EMCM
As part of the PIDON consortium Novio Tissue, EMCM has successfully developed a production process for insoluble highly purified type 1 collagen, derived from bovine tendons . This development further enhances the strategic position of EMCM as a developer and manufacturer of collagen based biomaterials for the healthcare industry.
March 26, 2012
Stichting Sanquin Bloedvoorziening & EMCM B.V. have entered into a strategic alliance
Stichting Sanquin Bloedvoorziening & EMCM B.V. have entered into a strategic alliance in the area of Tissue Processing, thus offering Dutch hospitals access to clean & sterile hygienically processed bone tissue processed under super critical gas technology (SCC02), in a quest to redefine orthopedic and cranial surgical procedures in the Netherlands.
September 15, 2011
EMCM successfully clears US-FDA Inspection
Medical Contract Manufacturing (EMCM) has successfully cleared a 4 day US-FDA QSIT audit on 15th September.
August 2, 2011
Interview with Ms. Valster and Mr. Babychan for the European Business Journal
Supporting Opportunities in medical manufacturing
November 15, 2010
EMCM profiteert van kennis in de regio, publicatie in Management Team
Innovatie, van idee tot succesvolle introductie.